[Assessment of safety and antihypertensive efficacy of a cardioselective beta-blocker nebivolol in patients with hypertension and concomitant chronic obstructive bronchitis]. / Otsenka bezopasnosti primeneniia i antigipertenzivnaia éffektivnost' beta1-kardioselektivnogo adrenoblokatora nebivolola u bol'nykh s arterial'noi gipertenziei v sochetanii s khronicheskim obstruktivnym bronkhitom.

Safety, tolerability and antihypertensive efficacy of a cardioselective beta-blocker nebivolol was studied in 30 patients with mild and moderate hypertension and concomitant stage I chronic obstructive bronchitis. Nebivolol (5 mg/day) was given for 1 month; in 5 patients complementary hydrochlorothiazide (12.5 mg/day) was required for sufficient antihypertensive effect. Nebivolol was well tolerated (only 1 patient complained of head ache), did not cause worsening of bronchitis and spirometric parameters, exerted no cardiodepressive action, and did not induce apparent disturbances of metabolism.

[Significance of blood ribose measurement by gas liquid chromatography in ischemic hear disease]. / Znachenie opredeleniia ribozy v krovi metodom gazozhidkostnoi khromatografii pri ishemicheskoi bolezni serdtsa.

A method for measuring serum ribose by gas liquid chromatography is described, prolonging the sample stability and simplifying its storage. Serum ribose content is decreased in patients with angina of effort (functional class III).